Jack Lin
Stock Analyst at Morgan Stanley
(0.90)
# 3,847
Out of 4,574 analysts
25
Total ratings
41.2%
Success rate
-5.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jack Lin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCM HUTCHMED (China) | Upgraded: Hold | $14 → $14 | $11.01 | +23.52% | 3 | May 28, 2026 | |
| HKG: 0013 HUTCHMED (China) Limited | Maintained: Hold | $21.45 → $21.30 | $17.54 | +21.44% | 3 | May 28, 2026 | |
| HKG: 9969 InnoCare Pharma Limited | Upgraded: Buy | $19.60 → $17.00 | $13.80 | +23.19% | 3 | May 28, 2026 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Maintained: Buy | $493.00 | $234.20 | +110.50% | 2 | Nov 20, 2025 | |
| HKG: 9926 Akeso, Inc. | Maintained: Buy | $215.00 | $99.50 | +116.08% | 3 | Nov 9, 2025 | |
| HKG: 9688 Zai Lab Limited | Maintained: Buy | $37.50 → $37.44 | $15.38 | +143.43% | 2 | Nov 6, 2025 | |
| HKG: 9995 RemeGen Co., Ltd. | Maintained: Hold | $89.00 | $83.20 | +6.97% | 2 | Oct 30, 2025 | |
| HKG: 1801 Innovent Biologics, Inc. | Maintained: Buy | $123.00 | $89.95 | +36.74% | 1 | Sep 22, 2025 | |
| HKG: 1952 Everest Medicines Limited | Maintained: Hold | $55.00 | $24.66 | +123.03% | 1 | Sep 22, 2025 | |
| HKG: 2162 Keymed Biosciences Inc. | Maintained: Buy | $93.50 | $82.80 | +12.92% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $48 | $19.22 | +149.74% | 3 | Sep 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22.00 | $10.73 | +105.03% | 1 | Sep 19, 2025 |
HUTCHMED (China)
May 28, 2026
Upgraded: Hold
Price Target: $14 → $14
Current: $11.01
Upside: +23.52%
HUTCHMED (China) Limited
May 28, 2026
Maintained: Hold
Price Target: $21.45 → $21.30
Current: $17.54
Upside: +21.44%
InnoCare Pharma Limited
May 28, 2026
Upgraded: Buy
Price Target: $19.60 → $17.00
Current: $13.80
Upside: +23.19%
Duality Biotherapeutics, Inc.
Nov 20, 2025
Maintained: Buy
Price Target: $493.00
Current: $234.20
Upside: +110.50%
Akeso, Inc.
Nov 9, 2025
Maintained: Buy
Price Target: $215.00
Current: $99.50
Upside: +116.08%
Zai Lab Limited
Nov 6, 2025
Maintained: Buy
Price Target: $37.50 → $37.44
Current: $15.38
Upside: +143.43%
RemeGen Co., Ltd.
Oct 30, 2025
Maintained: Hold
Price Target: $89.00
Current: $83.20
Upside: +6.97%
Innovent Biologics, Inc.
Sep 22, 2025
Maintained: Buy
Price Target: $123.00
Current: $89.95
Upside: +36.74%
Everest Medicines Limited
Sep 22, 2025
Maintained: Hold
Price Target: $55.00
Current: $24.66
Upside: +123.03%
Keymed Biosciences Inc.
Sep 22, 2025
Maintained: Buy
Price Target: $93.50
Current: $82.80
Upside: +12.92%
Sep 21, 2025
Maintained: Buy
Price Target: $50 → $48
Current: $19.22
Upside: +149.74%
Sep 19, 2025
Maintained: Buy
Price Target: $22.00
Current: $10.73
Upside: +105.03%